NeueHealth, Inc. (NEUE)
NYSE: NEUE · Real-Time Price · USD
6.27
-0.22 (-3.39%)
At close: Apr 4, 2025, 4:03 PM
6.35
+0.08 (1.28%)
After-hours: Apr 4, 2025, 7:21 PM EDT
NeueHealth Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Premiums & Annuity Revenue | 259.88 | 219.77 | 112.9 | 1,390 | 487.91 | Upgrade
|
| Total Interest & Dividend Income | 1.04 | 0.09 | -55.43 | 0.1 | 8.47 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | 80.13 | - | Upgrade
|
| Other Revenue | 675.73 | 940.94 | 693.69 | 42.47 | 18.51 | Upgrade
|
| Total Revenue | 936.66 | 1,161 | 751.16 | 1,513 | 514.89 | Upgrade
|
| Revenue Growth (YoY) | -19.31% | 54.53% | -50.35% | 193.86% | 83.45% | Upgrade
|
| Policy Benefits | 742.14 | 996.58 | 662.97 | 1,294 | 451.92 | Upgrade
|
| Depreciation & Amortization | 15.65 | 18.3 | 30.71 | 35.05 | 8.29 | Upgrade
|
| Selling, General & Administrative | 270.7 | 286.84 | 354.44 | 526.75 | 221.26 | Upgrade
|
| Provision for Bad Debts | 0.01 | 27.41 | 0.01 | - | - | Upgrade
|
| Total Operating Expenses | 1,029 | 1,329 | 1,048 | 1,856 | 681.47 | Upgrade
|
| Operating Income | -91.84 | -168.32 | -296.97 | -342.93 | -166.58 | Upgrade
|
| Interest Expense | -18.7 | -38.2 | -12.82 | -7.23 | - | Upgrade
|
| Other Non Operating Income (Expenses) | -3.66 | -13.97 | - | 1.23 | - | Upgrade
|
| EBT Excluding Unusual Items | -114.21 | -220.5 | -309.79 | -348.93 | -166.58 | Upgrade
|
| Merger & Restructuring Charges | -0.96 | -6.99 | -29.18 | -0.7 | -3.8 | Upgrade
|
| Impairment of Goodwill | - | -401.39 | - | - | - | Upgrade
|
| Asset Writedown | -14.61 | -0.3 | -42.61 | - | - | Upgrade
|
| Other Unusual Items | 30.31 | - | - | - | - | Upgrade
|
| Pretax Income | -99.46 | -629.17 | -381.58 | -349.63 | -170.38 | Upgrade
|
| Income Tax Expense | 2.6 | -1.43 | 3.66 | -26.52 | -9.16 | Upgrade
|
| Earnings From Continuing Ops. | -102.06 | -627.74 | -385.24 | -323.11 | -161.22 | Upgrade
|
| Earnings From Discontinued Ops. | 2.34 | -638.07 | -974.64 | -855.26 | -87.22 | Upgrade
|
| Net Income to Company | -99.72 | -1,266 | -1,360 | -1,178 | -248.44 | Upgrade
|
| Minority Interest in Earnings | -34.96 | 114.35 | -95.66 | -6.5 | - | Upgrade
|
| Net Income | -134.68 | -1,151 | -1,456 | -1,185 | -248.44 | Upgrade
|
| Preferred Dividends & Other Adjustments | 51.65 | 49.15 | 39.69 | - | - | Upgrade
|
| Net Income to Common | -186.33 | -1,201 | -1,495 | -1,185 | -248.44 | Upgrade
|
| Shares Outstanding (Basic) | 8 | 8 | 8 | 5 | 2 | Upgrade
|
| Shares Outstanding (Diluted) | 8 | 8 | 8 | 5 | 2 | Upgrade
|
| Shares Change (YoY) | 3.42% | 1.09% | 60.47% | 188.00% | 1.27% | Upgrade
|
| EPS (Basic) | -22.65 | -150.94 | -190.04 | -241.66 | -145.94 | Upgrade
|
| EPS (Diluted) | -22.65 | -150.94 | -190.04 | -241.66 | -145.94 | Upgrade
|
| Free Cash Flow | -125.55 | -2,729 | 207.02 | 51.65 | -63.71 | Upgrade
|
| Free Cash Flow Per Share | -15.26 | -343.15 | 26.31 | 10.53 | -37.42 | Upgrade
|
| Operating Margin | -9.80% | -14.50% | -39.53% | -22.66% | -32.35% | Upgrade
|
| Profit Margin | -19.89% | -103.43% | -199.06% | -78.31% | -48.25% | Upgrade
|
| Free Cash Flow Margin | -13.40% | -235.13% | 27.56% | 3.41% | -12.37% | Upgrade
|
| EBITDA | -76.2 | -144.15 | -246.39 | -307.44 | -158.29 | Upgrade
|
| EBITDA Margin | -8.13% | -12.42% | -32.80% | -20.32% | -30.74% | Upgrade
|
| D&A For EBITDA | 15.65 | 24.17 | 50.58 | 35.48 | 8.29 | Upgrade
|
| EBIT | -91.84 | -168.32 | -296.97 | -342.93 | -166.58 | Upgrade
|
| EBIT Margin | -9.80% | -14.50% | -39.53% | -22.66% | -32.35% | Upgrade
|
| Revenue as Reported | 936.66 | 1,161 | 751.16 | 1,513 | 514.89 | Upgrade
|
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Insurance template. Financial Sources.